ABSTRACT
The purpose of this study was to look at the serum levels of Visfatinin non-obese ordinary circulatory strain, non-obese hypertension and obesity hypertension. Research plan was Comparative cross sectional study. The Place and span was collaborating with the Institute of Medical Science in Lahore at the Graduate School of Medicine Laboratory of Lahore. This research included 81 subjects, each separated into 3 gatherings: non-obese normotensive, non-obese hypertensive and obesity hypertension. Circulatory strain level, BMI (Body Mass Index) and WHR (Waist to Hip Ratio) were estimated. Fasting blood tests were gathered to evaluate Visfatin levels in the serum. The results showed that the Mean serum Visfatin levels of 70.97 ± 50.30 ng/ml were seen in obese hypertensive patients contrasted with 33.71 ± 10.66 ng/ml and 5.21 ± 3.57 ng/ml for non-obese hypertensive and non-obese ordinary circulatory strain. It is concluded that Serum Visfatin levels can be utilized as biomarkers for assessing hypertension in obese and non-obese patients.